{
    "eid": "2-s2.0-85077930309",
    "title": "Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth",
    "cover-date": "2020-02-11",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Hepatitis B",
        "Hexavalent",
        "Immunogenicity",
        "Pentavalent",
        "Vaccine"
    ],
    "authors": [
        "Nawarat Posuwan",
        "Nasamon Wanlapakorn",
        "Sompong Vongpunsawad",
        "Palittiya Sintusek",
        "Elke Leuridan",
        "Pierre Van Damme",
        "Yong Poovorawan"
    ],
    "citedby-count": 3,
    "ref-count": 24,
    "ref-list": [
        "Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers",
        "Chronic hepatitis B virus infection in Asian countries",
        "The global impact of vaccination against hepatitis B: a historical overview",
        "Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand",
        "Impact of hepatitis B immunisation as part of the EPI",
        "Immunogenicity and Reactogenicity of Combined Tetravalent Diphtheria, Tetanus, Pertussis, and Hepatitis B Vaccine in Infants. Viral Hepatitis and Liver",
        "Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand",
        "Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination",
        "Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial",
        "Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage",
        "Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers",
        "Experience of combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine in Thailand",
        "Comparison study of combined DTPw-HB vaccines and separate administration of DTPw and HB vaccines in Thai children",
        "Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age",
        "Immunogenicity and safety of quinvaxem\u00ae (diphtheria, tetanus, whole-cell pertussis, hepatitis B and haemophilus influenzae type B vaccine) give to Vietnamese infants at 2 to 4 months of age",
        "A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers",
        "Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants",
        "Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants",
        "Persistence of hepatitis B immune memory until 9\u201310 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months",
        "Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy",
        "Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Antwerpen",
            "@id": "60012937",
            "affilname": "Universiteit Antwerpen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012937",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "North Bangkok",
            "@id": "109168253",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109168253",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "European Union, and Abbott",
        "GSK Biologicals",
        "National Vaccine Institute Thailand",
        "Rachadapisek Sompote Fund of Chulalongkorn University",
        "Ratchadaphiseksomphot Endowment Fund",
        "Thrasher Fund",
        "Bill Melinda Gates Foundation",
        "Pfizer",
        "Sanofi",
        "Thrasher Research Fund",
        "MSD",
        "King Chulalongkorn Memorial Hospital",
        "Takeda",
        "Chulalongkorn University 2561",
        "National Science and Technology Development Agency",
        "University of Antwerp",
        "Health Systems Research Institute",
        "Flemish government"
    ]
}